Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.
AUTOR(ES)
Guadagni, D N
RESUMO
An infusion of prostacyclin (PGI2) in four patients with pulmonary hypertension resulted in a dose-related decrease in the systemic and pulmonary vascular resistance and an increase in cardiac output. No selectivity for the pulmonary vasculature was observed and the drug was not therapeutically beneficial.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=482538Documentos Relacionados
- Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.
- Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
- Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
- Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.
- Acute circulatory effects of dopamine in patients with pulmonary hypertension.
